EBITDA: Income before interest, taxes, depreciation and amortization.
Instil Bio, Inc. (TIL) had EBITDA of $-15.01M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-13.59M |
|
-- |
|
-- |
|
$15.02M |
|
$-15.02M |
|
$1.44M |
|
$-13.59M |
|
$-13.59M |
|
$-13.59M |
|
$-13.59M |
|
$-13.59M |
|
$-13.59M |
|
$-15.02M |
|
|
EBITDA |
$-15.01M |
6.76M |
|
6.76M |
|
$-2.01 |
|
$-2.01 |
|
| Balance Sheet Financials | |
$196.26M |
|
$0.14M |
|
$15.50M |
|
$211.77M |
|
$5.70M |
|
$84.61M |
|
$85.65M |
|
$91.35M |
|
$120.42M |
|
$120.42M |
|
$120.42M |
|
6.78M |
|
| Cash Flow Statement Financials | |
$-29.54M |
|
$17.66M |
|
$7.29M |
|
$10.63M |
|
$6.08M |
|
$-4.55M |
|
$7.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
34.45 |
|
-- |
|
-- |
|
0.41 |
|
0.70 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-29.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.28% |
|
-11.28% |
|
-6.42% |
|
-6.63% |
|
$17.76 |
|
$-4.37 |
|
$-4.37 |
|